Skip to main navigation
Home
  • Our Company
    • Biopharmaceutical Acceleration Model
    • The Trusted® Process
    • Our Leadership
    • Our Culture
    • Perspectives
    • Events
    • Awards
    • Brand Directory
    • Site Relationships
    • Our Office Locations
    • Legal
  • Solutions
    • Clinical Development
      • Full Services
        • Bioanalytical Solutions
        • Early Phase
        • Phase II - III
        • Phase IIIb - IV
        • Real World Evidence and Late Phase
      • Functional Service Providers
        • Biostatistics and Statistical Programming
        • Clinical Data Management
        • Clinical Development Services Project Management
        • Clinical Staffing Solutions
        • Drug Safety and Pharmacovigilance
        • Investigator Management Solutions
        • Medical Writing and Communications
        • Medical and Scientific Affairs
        • Next Generation Clinical Development
        • Patient Recruitment
        • Project Management
        • Quality Risk Management
        • Rater Training
        • Site Start Up
        • Site and Patient Access
        • SRG Monitoring
        • Trial Master File Operations
    • Commercialization
      • Advertising
      • Behavioral Insights
      • Brand Commercialization
      • Brand Naming and Development
      • Clinical Field Teams
      • Commercial Model of the Future
      • Commercial Recruiting Solutions
      • Communications
      • Digital and Social Media
      • Health Economics and Outcomes Research
      • Market Research, Analytics, Insights
      • Medical Affairs Transformation
      • Medical Communications
      • Medication Engagement
      • Policy and Advocacy
      • Portfolio Strategy
      • Promotional Field Teams and Support
      • Public Relations
      • REMS and Risk Management (PMO)
      • Reputation and Risk Management
      • Training and Learning Solutions
    • Consulting
      • Brand Commercialization
      • Commercial Model of the Future
      • Health Economics and Outcomes Research
      • Market Access
      • Medical Affairs Transformation
      • Next Generation Clinical Development
      • Portfolio Strategy
      • Quality Consulting
      • REMS and Risk Management (PMO)
      • Regulatory Consulting
  • Therapeutic Expertise
    • Therapeutic Areas
      • Cardiovascular
      • CNS Analgesia
      • CNS Clinical Surveillance Team
      • CNS Neurology
      • CNS Psychiatry
      • Endocrine and Metabolic
      • Gastroenterology
      • Immunology and Inflammation
      • Infectious Disease
      • Oncology and Hematology
      • Ophthalmology
      • Respiratory
    • Cross-Functional Solutions
      • Biosimilars
      • Biotechnology Solutions Platform
      • Medical Devices and Diagnostics
      • Pediatrics
      • Rare Diseases
  • Careers
  • News
    • In The News
    • Press Releases
    • Press Kit
  • Investors
  • Suppliers
  • Contact

Search form

Home Investors
Annual Reports

Annual Reports

Q3 2018 Syneos Health Inc. Earnings Conference Call

Scroll
  • Overview
  • News & Events
    • News
    • Events and Presentations
  • Stock Performance
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Management Team
    • Board of Directors
    • Committee Composition
    • Governance Documents
  • Financials
    • SEC Filings
    • Quarterly Results
    • Annual Reports
  • Investor Resources
    • Investor FAQs
    • Investor Contact
    • Forward-Looking Statement

Annual Reports

Syneos Health 2017 Annual Report 654 KB
INC Research 2016 Annual Report 1.6 MB
INC Research 2015 Annual Report 1.9 MB
INC Research 2014 Annual Report 1.7 MB

Sign Up for Email Alerts

 
Subscribe Now
Interested in Syneos Health?
Get In Touch
Connect

About Syneos Health

Syneos Health™ (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 23,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit syneoshealth.com.

Contact Us
map HQ
Corporate Headquarters
  • 3201 Beechleaf Court
  • Suite 600
  • Raleigh, NC 27604-1547

  • Phone:+1 919 876 9300
  • Fax:+1 919 876 9360
  • Toll-free:+1 866 462 7373
Menu
  • Solutions
  • Therapeutic Expertise
  • Brand Directory
  • Careers
  • Study Participants
  • Investigators
  • Media
  • UK Tax Statement
  • Business Ethics Helpline
© 2018 Syneos Health. All Rights Reserved.
  • Terms Of Use
  • Privacy Policy